KRAS and neoplasm: For example, mutations in KRAS proto-oncogene and GTPase(KRAS) exist in most tumours, such as lung cancer, colon cancer, and pancreatic cancer [75,76,77], and introduce mutated KRAS (KRASG12D) into normal human breast cells, which can initiate breast cancer [78].